(R)-7-(benzyloxy)-12-((R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine
2448416-75-7
Pharmaceutical Grade
90%
Shanghai Port or Shenzhen Port
H&D
A temperature-controlled box with a capacity of up to 10g
2025-03-26
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Product Details
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aR)-rel-
Other Name:1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aR)-rel-;(R)-7-(Benzyloxy)-12-((R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione;INT1 enantiomer
CAS No.:2448416-75-7
Molecular Formula:C31H25F2N3O4S
Molecular Weight:573.61
Categories:
Characteristics-
Density:
1.51±0.1 g/cm3(Predicted)
Boiling Point:741.7±70.0 °C(Predicted)
PKA:-1.31±0.40(Predicted)
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Location:
Hengfeng Wanda (Hubei) Pharmaceutical Technology Co., LTD., Hongshan District, Wuhan City, Hubei Province, China
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
150 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2023
Company Certificates-
Brand certification certificate
-
QUALITY MANAGEMENT SYSTEM CERTIFICATE
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Dapagliflozin Impurity 11-- (2S,3R,4R,5R)-1-(4-chloro-3-(4-ethoxybenzyl)phenyl)hexane-1,2,3,4,5,6-hexaol
Pharmaceutical Grade / 90%
-
-
-
-
Upadacitinib Impurity 21-- (3R,4S)-benzyl 3-(2-chloroacetyl)-4-ethylpyrrolidine-1-carboxylate
Pharmaceutical Grade / 90%
-
-
-
-
Upadacitinib Impurity 1((3S,4S)-benzyl 3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate)
Pharmaceutical Grade / 90%
-

